SLC5A2 and COVID-19: The increase in SGLT2 levels in coronary ECs of COVID-19 patients (high cytokine levels) rendered the cells dysfunctional and enhanced aging and inflammation, platelet adhesion, platelet aggregation, and thrombin production [27].